Skip to main content

Table 2 Summary of antibodies which can be used in differential diagnosis of ACA and SCC

From: Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

 

ACA

SCC

HNF-1β

++

-

(75%)

(2%)

p63/p40

−+

+++

(7% / 4%)

(100%)

CEA

+++

+++

(86%)

(91%)

ER

+−

+−

(16%)

(11%)

PR

−+

-

(9%)

(1%)

D2-40

-

++

(0%)

(54%)

  1. ACA - adenocarcinoma; SCC - squamous cell carcinoma.
  2. In brackets is a percentage of positive cases in our study.